User login
Key clinical point: Higher rehabilitation dose (>8 physical/occupational therapy visits) improved physical function in adults with rheumatoid arthritis (RA) who reported new rehabilitation visits after at least 1 year without rehabilitation visits.
Major finding: Worse physical function at baseline was associated with a higher rehabilitation dose (adjusted odds ratio [aOR] 1.29; 95% CI 1.04-1.60). Higher vs. lower rehabilitation dose was also associated with clinically favorable changes in physical function (aOR 1.41; 95% CI 1.03-1.92).
Study details: This prospective cohort analysis evaluated the data of 1,381 adults with RA from the FORWARD registry who reported new rehabilitation visits of low/medium/high dose over 6 months after no rehabilitation visits for past ≥1 year.
Disclosures: This study did not receive any specific funding. LM Thoma and E Wellsandt reported receiving support from the Rheumatology Research Foundation and/or National Institutes of Health.
Source: Thoma LM et al. Examining rehabilitation dose in adults with rheumatoid arthritis: Association with baseline factors and change in clinical outcomes. Arthritis Care Res (Hoboken). 2022 (Sep 12). Doi: 10.1002/acr.25019
Key clinical point: Higher rehabilitation dose (>8 physical/occupational therapy visits) improved physical function in adults with rheumatoid arthritis (RA) who reported new rehabilitation visits after at least 1 year without rehabilitation visits.
Major finding: Worse physical function at baseline was associated with a higher rehabilitation dose (adjusted odds ratio [aOR] 1.29; 95% CI 1.04-1.60). Higher vs. lower rehabilitation dose was also associated with clinically favorable changes in physical function (aOR 1.41; 95% CI 1.03-1.92).
Study details: This prospective cohort analysis evaluated the data of 1,381 adults with RA from the FORWARD registry who reported new rehabilitation visits of low/medium/high dose over 6 months after no rehabilitation visits for past ≥1 year.
Disclosures: This study did not receive any specific funding. LM Thoma and E Wellsandt reported receiving support from the Rheumatology Research Foundation and/or National Institutes of Health.
Source: Thoma LM et al. Examining rehabilitation dose in adults with rheumatoid arthritis: Association with baseline factors and change in clinical outcomes. Arthritis Care Res (Hoboken). 2022 (Sep 12). Doi: 10.1002/acr.25019
Key clinical point: Higher rehabilitation dose (>8 physical/occupational therapy visits) improved physical function in adults with rheumatoid arthritis (RA) who reported new rehabilitation visits after at least 1 year without rehabilitation visits.
Major finding: Worse physical function at baseline was associated with a higher rehabilitation dose (adjusted odds ratio [aOR] 1.29; 95% CI 1.04-1.60). Higher vs. lower rehabilitation dose was also associated with clinically favorable changes in physical function (aOR 1.41; 95% CI 1.03-1.92).
Study details: This prospective cohort analysis evaluated the data of 1,381 adults with RA from the FORWARD registry who reported new rehabilitation visits of low/medium/high dose over 6 months after no rehabilitation visits for past ≥1 year.
Disclosures: This study did not receive any specific funding. LM Thoma and E Wellsandt reported receiving support from the Rheumatology Research Foundation and/or National Institutes of Health.
Source: Thoma LM et al. Examining rehabilitation dose in adults with rheumatoid arthritis: Association with baseline factors and change in clinical outcomes. Arthritis Care Res (Hoboken). 2022 (Sep 12). Doi: 10.1002/acr.25019